Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
Christopher P. Cannon, MD
Cardiovascular Innovation, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School, Boston, MA
Remote faculty, Clinician-Scientist, CPC Clinical Research Institute
Dr. Cannon is a Professor of Medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He serves as Education Director in the Cardiovascular Innovation group, and has recently joined the remote faculty as a Clinician Scientist at the CPC Clinical Research Institute. In the past, he has worked as an investigator in the TIMI Study Group. He has been principal investigator of more than 20 multicenter clinical trials, including TACTICS-TIMI 18, PROVE IT, IMPROVE IT, RE-DUAL PCI and VERTIS-CV trials. At Cardiovascular Innovation, he is helping implement quality improvement programs using telemedicine for lipids, hypertension and diabetes, and at CPC Clinical Research as he is helping lead pragmatic clinical trials.
Meet the trialist - ASCEND - Randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes & Randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 people with diabetes